N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide

C19H22N6O3S — CID 166209436

IUPACN-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide
SMILESNC(=O)CCn1ccc(NC(=O)CCc2nc3sc4c(c3c(=O)[nH]2)CCCC4)n1
InChIInChI=1S/C19H22N6O3S/c20-13(26)7-9-25-10-8-15(24-25)21-16(27)6-5-14-22-18(28)17-11-3-1-2-4-12(11)29-19(17)23-14/h8,10H,1-7,9H2,(H2,20,26)(H,21,24,27)(H,22,23,28)
InChIKeyJTQVFYUHLHZBIC-UHFFFAOYSA-N
MW414.49 g/mol
LogP1.51
Rot. Bonds7

About N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide

N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide (PubChem CID 166209436) has the molecular formula C19H22N6O3S and a molecular weight of 414.49 g/mol. Its IUPAC name is N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide.

Molecular Properties

Compound NameN-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide
PubChem CID166209436
Molecular FormulaC19H22N6O3S
Molecular Weight414.49 g/mol
Exact Mass414.15
IUPAC NameN-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide
SMILESNC(=O)CCn1ccc(NC(=O)CCc2nc3sc4c(c3c(=O)[nH]2)CCCC4)n1
InChIInChI=1S/C19H22N6O3S/c20-13(26)7-9-25-10-8-15(24-25)21-16(27)6-5-14-22-18(28)17-11-3-1-2-4-12(11)29-19(17)23-14/h8,10H,1-7,9H2,(H2,20,26)(H,21,24,27)(H,22,23,28)
InChIKeyJTQVFYUHLHZBIC-UHFFFAOYSA-N
XLogP1.51
TPSA135.76 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds7
Heavy Atoms29
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500414.49
LogP ≤ 51.51
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide?
The IUPAC name of N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide (CID 166209436) is N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide.
What is the SMILES notation for N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide?
The canonical SMILES for N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide is NC(=O)CCn1ccc(NC(=O)CCc2nc3sc4c(c3c(=O)[nH]2)CCCC4)n1.
What is the InChIKey of N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide?
The InChIKey is JTQVFYUHLHZBIC-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H22N6O3S/c20-13(26)7-9-25-10-8-15(24-25)21-16(27)6-5-14-22-18(28)17-11-3-1-2-4-12(11)29-19(17)23-14/h8,10H,1-7,9H2,(H2,20,26)(H,21,24,27)(H,22,23,28).
What are the key properties of N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide?
N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide has a molecular weight of 414.49 g/mol, XLogP of 1.51, 7 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-(3-amino-3-oxopropyl)pyrazol-3-yl]-3-(4-oxo-5,6,7,8-tetrahydro-3H-[1]benzothiolo[2,3-d]pyrimidin-2-yl)propanamide is sourced from PubChem (CID 166209436), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).